Comparasion of Autogenic Inhibition and Reciprocal Inhibition Muscle Energy Techniques (METS) in Piriformis Syndrome
NCT ID: NCT06460675
Last Updated: 2024-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
32 participants
INTERVENTIONAL
2024-02-01
2024-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Instrument-Assisted Soft Tissue Mobilization Versus PNF Stretching in Athletes With Piriformis Syndrome
NCT07090356
Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques in Iliotibial Band Syndrome
NCT06867159
Comparison of Intermittent Occlusion and Static Stretching
NCT04574661
Effects of Movement Pattern Training Versus Proprioceptive Neuromuscular Training in Footballers With Groin Pain
NCT06819384
Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia
NCT04674878
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized clinical trial will be conducted at DHQ Hospital Jhang over six months. The sample size will consist of 32 participants. Participants who meet the inclusion criteria will be taken through a non-probability convenience sampling technique, that will be randomized through a sealed envelope method. 16 Participants will be assigned to Group A that will be treated with the Autogenic Inhibition Muscle Energy Technique, 16 Participants will be assigned to Group B and will be treated with Reciprocal Inhibition Muscle Energy Technique at the frequency of 1 set and 3 repetitions per session for two sessions per week and total six sessions for three weeks with follow up at one month. The duration of contraction is 7-10 seconds. Pre and post-intervention values will be taken on the 1st day in the 3rd week and at one-month follow-up. Data will be collected using various assessment tools, including the FAIR test, Freiberg test, Lasegue test, Beatty test, Pace sign, Numeric Pain Rating Scale (NPRS), and Universal Goniometer. Pre-intervention assessments will be conducted for all two groups. The effects of the interventions will be measured either by parametric or non-parametric tests after assessing the normality of data by the Shapiro-Wilk test Independent t-test. Data analysis will be performed by using SPSS 25 software.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Autogenic Inhibition Muscle Energy Technique
This group will receive Autogenic Inhibition Muscle Energy Technique
Autogenic Inhibition Muscle Energy Technique
No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per weeks for 3 weeks (40 Min per Session)
Reciprocal Inhibition Muscle Energy Technique
No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per week for 3 weeks (40 Min per Session)
Reciprocal Inhibition Muscle Energy Technique
This group will receive Reciprocal Inhibition Muscle Energy Technique
Autogenic Inhibition Muscle Energy Technique
No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per weeks for 3 weeks (40 Min per Session)
Reciprocal Inhibition Muscle Energy Technique
No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per week for 3 weeks (40 Min per Session)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Autogenic Inhibition Muscle Energy Technique
No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per weeks for 3 weeks (40 Min per Session)
Reciprocal Inhibition Muscle Energy Technique
No of repetitions: 1 set with 3 repetitions No of Sessions per week: 2 per week for 3 weeks (40 Min per Session)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with Piriformis syndrome using the Piriformis FAIR test, Freiberg test, Lasegue test, Beaty test, and pace sign.
* Hip pain with a threshold of NPRS 3-6.
* Limited ROM of Hip Internal Rotation and Abduction measured using a goniometer.
* Buttock pain ≥ 3 months.
* Pain with prolonged sitting (more than 20 minutes)
Exclusion Criteria
* History of Trauma or Fracture
* Other Systemic Conditions
* Postural abnormality/deformity
* Diagnosed Psychological Disorders
* Pregnancy
25 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rabiya Noor, PhD
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IIMCT Railway General Hospital
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Sadiq M, Hussain SA, Meganath P. 'Hand on hip'sign: A novel screening test and diagnostic tool in piriformis syndrome. Journal of Orthopaedics, Trauma and Rehabilitation. 2020:2210491720961113.
Siahaan YMT, Tiffani P, Tanasia A. Ultrasound-Guided Measurement of Piriformis Muscle Thickness to Diagnose Piriformis Syndrome. Front Neurol. 2021 Sep 7;12:721966. doi: 10.3389/fneur.2021.721966. eCollection 2021.
Tanveer F, Shahid S. Frequency of Piriformis tightness in professionals middle aged women. Rawal Medical Journal. 2018;43(4):685-.
Hopayian K, Danielyan A. Four symptoms define the piriformis syndrome: an updated systematic review of its clinical features. Eur J Orthop Surg Traumatol. 2018 Feb;28(2):155-164. doi: 10.1007/s00590-017-2031-8. Epub 2017 Aug 23.
Siahaan YMT, Ketaren RJ, Hartoyo V, Tiffani P. The predisposing factors of piriformis syndrome: Study in a referral hospital. MNJ (Malang Neurology Journal). 2019;5(2):76-9.
Wu YY, Guo XY, Chen K, He FD, Quan JR. Feasibility and Reliability of an Ultrasound Examination to Diagnose Piriformis Syndrome. World Neurosurg. 2020 Feb;134:e1085-e1092. doi: 10.1016/j.wneu.2019.11.098. Epub 2019 Nov 25.
Islam F, Mansha H, Gulzar K, Raza A, Raffique A, Haider S. Prevalence Of Piriformis Muscle Syndrome Among Individuals with Low Back Pain: Piriformis Muscle Syndrome Among Individuals with Low Back Pain. Pakistan Journal of Health Sciences. 2022:48-52.
Probst D, Stout A, Hunt D. Piriformis Syndrome: A Narrative Review of the Anatomy, Diagnosis, and Treatment. PM R. 2019 Aug;11 Suppl 1:S54-S63. doi: 10.1002/pmrj.12189. Epub 2019 Jul 22.
Ahmad Siraj S, Dadgal R. Physiotherapy for Piriformis Syndrome Using Sciatic Nerve Mobilization and Piriformis Release. Cureus. 2022 Dec 26;14(12):e32952. doi: 10.7759/cureus.32952. eCollection 2022 Dec.
Chang C, Jeno SH, Varacallo MA. Anatomy, Bony Pelvis and Lower Limb: Piriformis Muscle. 2023 Nov 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK519497/
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/RCR & AHS/23/01114
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.